Author: Yadav, Yogesh; Sharma, Deepti; Kaushik, Kumar; Kumar, Vineet; Jha, Amitabh; Prasad, Ashok K.; Len, Christophe; Malhotra, Sanjay V.; Wengel, Jesper; Parmar, Virinder S.
Title: Synthetic, Structural, and Anticancer Activity Evaluation Studies on Novel Pyrazolylnucleosides Document date: 2019_10_30
ID: 15rg623y_22
Snippet: The anticancer and toxicity of compounds 5a-e and 6a-e were evaluated by using the National Cancer Institute′s 60 human cancer cell lines. Compounds 5a-e, where the sugar is attached to N-1 of the pyrazole ring, were found to be inactive against all the cell lines irrespective of the substituent on the aromatic ring. In the other series, compounds 6a, 6b, and 6c with 4-methyl, 4-methoxy, and 4-fluoro substituents, respectively, at the aromatic .....
Document: The anticancer and toxicity of compounds 5a-e and 6a-e were evaluated by using the National Cancer Institute′s 60 human cancer cell lines. Compounds 5a-e, where the sugar is attached to N-1 of the pyrazole ring, were found to be inactive against all the cell lines irrespective of the substituent on the aromatic ring. In the other series, compounds 6a, 6b, and 6c with 4-methyl, 4-methoxy, and 4-fluoro substituents, respectively, at the aromatic ring were also inactive. However, compounds 6d and 6e with 4-chloro and 4-bromo substituents at the aromatic ring, respectively, showed inhibition against multiple anticancer cell lines. The GI50 (cytostatic parameter) and LC50 (toxicity parameter) values of 6d and 6e for the selected cell lines are given in Table 5 . Compound 6d showed inhibition in 19 cell lines, and was most active against the renal cancer cell line UO-31 and breast cancer cell line HS 578T with GI50 < 20 µM in both cases. The most active compound was 6e, which showed moderate inhibition in 39 cell lines. It showed significant inhibition against lung cancer cell line Hop-92 with a GI50 of 9.3 µM and breast cancer cell line HS 578T with a GI50 of 3.0 µM. Most importantly, both compounds (6d and 6e) did not show any toxicity, even at the highest concentration tested, as indicated by their high LC50 values.
Search related documents:
Co phrase search for related documents- moderate inhibition and pyrazole ring: 1
- moderate inhibition and renal cancer cell line: 1
- moderate inhibition and significant inhibition: 1, 2, 3, 4
- moderate inhibition and toxicity anticancer: 1
- moderate inhibition and toxicity parameter: 1
- National Cancer and pyrazole ring: 1
- National Cancer and renal cancer cell line: 1
- National Cancer and significant inhibition: 1
- National Cancer and toxicity anticancer: 1, 2
- National Cancer and toxicity parameter: 1
- pyrazole ring and renal cancer cell line: 1
- pyrazole ring and significant inhibition: 1
- pyrazole ring and toxicity anticancer: 1
- pyrazole ring and toxicity parameter: 1
- renal cancer cell line and significant inhibition: 1
- renal cancer cell line and toxicity anticancer: 1
- renal cancer cell line and toxicity parameter: 1
- significant inhibition and toxicity anticancer: 1
- significant inhibition and toxicity parameter: 1
Co phrase search for related documents, hyperlinks ordered by date